Optometry - Journal of the American Optometric Association
Volume 75, Issue 7 , Pages 430-444 , July 2004

Anterior scleritis: three case reports and a review of the literature

  • David D. Castells, O.D.

      Affiliations

    • Corresponding Author InformationCorrespondence address: Illinois College of Optometry 3241, South Michigan Avenue, Chicago, Illinois 60616.

References 

  1. Anderson B. Ocular lesions in relapsing polychondritis and other rheumatoid syndromes. The Edward Jackson memorial lecture. Am J Ophthalmol. 1967;64:35–50
  2. Mann WA, Markson DE. Case of recurrent iritis and episcleritis on rheumatic basis treated with ACTH. Am J Ophthalmol. 1950;33:459–461
  3. Viswalingham A. Case of sclerosing keratitis profunda. Br J Ophthalmol. 1936;20:449–455
  4. Wood DJ. Inflammatory diseases in eye caused by gout. Br J Ophthalmol. 1936;20:510–519
  5. Williamson J. Incidence of eye disease in cases of connective tissue disease. Trans Ophthalmol Soc U K. 1974;94:742–752
  6. Foster CS, Sainz de la Maza M. The sclera. New York: Springer-Verlag; 1994;
  7. Callina CL, Raizman MB. Immunologic disorders of the sclera and conjunctiva. J Ophthalmic Nurs Technol. 1995;14:267–273
  8. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396
  9. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191
  10. McMullen M, Kovarik G, Hodge WG. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis. Can J Ophthalmol. 1999;34:217–221
  11. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471
  12. Lachmann S, Hazleman BM, Watson PG. Scleritis and associated disease. Br Med J. 1978;1:88–90
  13. Lyne A, Pitkearhly DA. Episcleritis and scleritis association with connective tissue disease. Arch Ophthalmol. 1968;80:171–176
  14. Niemann KK, Bartlett JD, Heck LW, et al. Nodular scleritis: case report involving immunosuppressive therapy. J AM OPTOM ASSOC. 1997;68:782–787
  15. Magargal LE, Donoso LA, Goldberg RE, et al. Ocular manifestations of relapsing polychondritis. Retina. 1981;1:96–99
  16. Foster CS. Immunosuppressive therapy for external ocular inflammatory disease. Ophthalmology. 1980;87:140–150
  17. Barr CC, Davis H, Culbertson WW. Rheumatoid scleritis. Ophthalmology. 1981;88:1269–1273
  18. Watson PG. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc UK. 1982;102(pt 2):257–281
  19. Sarkis HS. Episcleritis and scleritis: diagnosis and therapy. Semin Ophthalmol. 1996;11:79–92
  20. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995;102:687–692
  21. Jayson MI, Jones DE. Rheumatoid arthritis and scleritis. Trans Ophthalmol Soc UK. 1971;91:189–197
  22. Sevel D. Rheumatoid nodule of the sclera. (A type of necrogranulomatous scleritis). Trans Ophthalmol Soc UK. 1965;85:357–367
  23. Smith J. Ocular complication of rheumatic fever and rheumatoid arthritis. Am J Ophthalmol. 1957;43:575–582
  24. Sainz de la Maza M. Scleritis immunopathology and therapy. Dev Ophthalmol. 1999;30:84–90
  25. Gupta A, Bansal RK, Bambery P. Posterior scleritis related fundal mass in a patient with rheumatoid arthritis. Scand J Rheumatol. 1992;21:254–256
  26. Fraunfelder FT, Watson PG. Evaluation of eyes enucleated for scleritis. Br J Ophthalmol. 1976;60:227–230
  27. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Ophthalmology. 1994;101(7):1281–1286(discussion 1287-8)
  28. Watson PG. The diagnosis and management of scleritis. Ophthalmology. 1980;87:716–720
  29. Smith JR, Chee SP. Nodular anterior scleritis associated with ocular trauma. Singapore Med J. 2001;42:180–190
  30. O’Donoghue E, Lightman S, Tuft S, et al. Surgically induced necrotising sclerokeratitis (SINS)—precipitating factors and response to treatment. Br J Ophthalmol. 1992;76:17–21
  31. Cameron ME. Preventable complications of pterygium excision with beta-irradiation. Br J Ophthalmol. 1972;56:52–56
  32. Gross SA, von Noorden GK, Jones DB. Necrotizing scleritis and transient myopia following strabismus surgery [see comments]. Ophthalmic Surg. 1993;24:839–841
  33. Lin CP, Shih MH, Tsai MC. Clinical experiences of infectious scleral ulceration: a complication of pterygium operation. Br J Ophthalmol. 1997;81:980–983
  34. Lin HC, Ku WC, Lin KK, et al. Surgical management of scleral perforation after pterygium excision. Ophthalmic Surg Lasers. 2002;33:275–279
  35. Thurairajan G, Hope-Ross MW, Situnayake RD, et al. Polyarthropathy, orbital myositis, and posterior scleritis: an unusual adverse reaction to influenza vaccine. Br J Rheumatol. 1997;36:120–123
  36. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984;91:1253–1263
  37. Mackenzie W. Practical treatise of the diseases of the eye. London; 1830.
  38. Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999;106:1328–1333
  39. Watson PG. Management of scleral disease. Trans Ophthalmol Soc UK. 1966;86:151–167
  40. McGavin DD, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol. 1976;60(3):192–226
  41. Lyne AJ, Pitkeathley DA. Episcleritis and scleritis. Association with connective tissue disease. Arch Ophthalmol. 1968;80:171–176
  42. Hemady R, Sainz de la Maza M, Raizman MB, et al. Six cases of scleritis associated with systemic infection. Am J Ophthalmol. 1992;114:55–62
  43. Bernauer W, Daicker B. Inflammatory cellular infiltration in scleritis. Ophthalmologe. 1995;92:46–48German
  44. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery. A clinicopathologic study. Ophthalmology. 1991;98:1720–1726
  45. Zamir E, Read RW, Rao NA. Self-inflicted anterior scleritis. Ophthalmology. 2001;108:192–195
  46. Basti S, Gopinathan U, Gupta S. Nocardial necrotizing scleritis after trauma. Successful outcome using cefazolin. Cornea. 1994;13:274–276
  47. Rosenbaum JT, Robertson JE. Recognition of posterior scleritis and its treatment with indomethacin. Retina. 1993;13:17–21
  48. Benson WE, Shields JA, Tasman W, et al. Posterior scleritis. A cause of diagnostic confusion. Arch Ophthalmol. 1979;97:1482–1486
  49. Sainz de la Maza M, Foster CS, Jabbur NS, et al. Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol. 2002;120:15–19
  50. Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis ‘corneal melt’ and rheumatoid arthritis: a case series. Rheumatology (Oxford). 1999;38:1245–1248
  51. Mohan M, Panda A, Pattnaik NK, et al. Corneomalacia perforans in a patient with rheumatoid arthritis. Can J Ophthalmol. 1984;19:237–239
  52. Brown SI, Grayson M. Marginal furrows. A characteristic corneal lesion of rheumatoid arthritis. Arch Ophthalmol. 1968;79:563–567
  53. Sainz de la Maza M, Foster CS, Jabbur NS. Scleritis-associated uveitis. Ophthalmology. 1997;104:58–63
  54. Fong LP, Sainz de la Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology. 1991;98:472–479
  55. Young RD, Watson PG. Microscopical studies of necrotizing scleritis. II. Collagen degradation in the scleral stroma. Br J Ophthalmol. 1984;68:781–789
  56. Harper SL, Foster CS. The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin. 1998;38:1–19
  57. Rao NA, Marak GE, Hidayat AA. Necrotizing scleritis. A clinico-pathologic study of 41 cases. Ophthalmology. 1985;92:1542–1549
  58. Rao NA. In:  O’Connor G,  Chandler JW editor. Etiology of scleritis. Advances in immunology and immunopathology of the eye. New York: Masson; 1985;
  59. Bernauer W, Buchi ER, Daicker B. Immunopathological findings in posterior scleritis. Int Ophthalmol. 1994;18:229–231
  60. Di Girolamo N, Lloyd A, McCluskey P, et al. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997;150:653–666
  61. Aydin P, Akova YA, Kadayifcilar S. Anterior segment indocyanine green angiography in scleral inflammation. Eye. 2000;14(Pt. 2):211–215
  62. Haruyama M, Yuzawa M, Kawamura A, et al. Indocyanine green angiographic findings of chorioretinal folds. Jpn J Ophthalmol. 2001;45:293–300
  63. Rosenfeld SI, Kronish JW, Schweitzer WA, et al. Topical cyclosporine for treating necrotizing scleritis letter. Arch Ophthalmol. 1995;113:20–21
  64. Hakin KN, Ham J, Lightman SL. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Br J Ophthalmol. 1991;75:337–339
  65. Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology. 1993;100:1372–1376
  66. Medway DC, Donzis DM, Donzis PB. Ketoprofen in the treatment of scleritis. Am J Ophthalmol. 1991;111:249–250
  67. Hakin KN, Watson PG. Systemic associations of scleritis. Int Ophthalmol Clin. 1991;31:111–129
  68. Hayreh SS, Watson PG. Prednisolone-21-stearoylglycolate in scleritis. Br J Ophthalmol. 1970;54:394–398
  69. Mondino BJ, Phinney RB. Treatment of scleritis with combined oral prednisone and indomethacin therapy. Am J Ophthalmol. 1988;106:473–479
  70. McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105:793–797
  71. Croasdale CR, Brightbill FS. Subconjunctival corticosteroid injections for nonnecrotizing anterior scleritis. Arch Ophthalmol. 1999;117:966–968
  72. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol. 1997;32:965–973
  73. Levy MJ, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42:1255–1259
  74. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum. 2001;30:217–241
  75. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85
  76. Afshari NA, Afshari MA, Foster CS. Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep. 2001;3:453–458
  77. Lyons CJ, Dart JK, Aclimandos WA, et al. Sclerokeratitis after keratoplasty in atopy. Ophthalmology. 1990;97:729–733
  78. Wilder-Smith E, Roelcke U. Cogan's syndrome. J Clin Neuroophthalmol. 1990;10:261–265
  79. Haynes BF, Fishman ML, Fauci AS, et al. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. Am J Med. 1977;63:131–141
  80. Bartlett JD, Siret DJ. Clinical ocular pharmacology. 4th ed. Boston: Butterworth Heinemann; 2001;
  81. Schuettenberg SP. Nodular scleritis, episcleritis and anterior uveitis as ocular complications of Crohn's disease. J AM OPTOM ASSOC. 1991;62:377–381
  82. Soukiasian SH, Foster CS, Raizman MB. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol. 1994;118:601–611
  83. Nanda M, Pflugfelder SC, Holland S. Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol. 1991;109:503–505
  84. Loeffler KU, McLean IW. Bilateral necrotizing scleritis and blindness in the myelodysplastic syndrome presumably due to relapsing polychondritis. Acta Ophthalmol Scand. 2000;78:228–231
  85. Isaak BL, Liesegang TJ, Michet CJ. Ocular and systemic findings in relapsing polychondritis. Ophthalmology. 1986;93:681–689
  86. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc. 1980;55:146–155
  87. Simmons IG, Kritzinger EE, Murray PI. Posterior scleritis and polymyalgia rheumatica. Eye. 1997;11(Pt 5):727–728
  88. Watson PG, Hazleman B. The sclera and systemic disease. Philadelphia: WB Saunders; 1976;
  89. Heiligenhaus A, Dutt JE, Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye. 1996;10(Pt 4):425–432
  90. Matsuo T, Kono R, Matsuo N, et al. Incidence of ocular complications in rheumatoid arthritis and the relation of keratoconjunctivitis sicca with its systemic activity. Scand J Rheumatol. 1997;26:113–116
  91. Smith JR, Rosenbaum JT. Case reports and small case series: scleritis occurring in association with Takayasu disease. Arch Ophthalmol. 2001;119:778–779
  92. Narag RB, Samuels AJ, Orlin SE, et al. Polyarteritis nodosa complicated by severe progressive scleritis letter. J Rheumatol. 1999;26:1213–1214
  93. Rosenbaum JT, Becker MD. The tyranny of the anecdote: Waldenstrom's macroglobulinemia and scleritis. Ocul Immunol Inflamm. 2000;8:111–113
  94. Bullen CL, Liesegang TJ, McDonald TJ, et al. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983;90:279–290
  95. Krist D, Wenkel H. Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology. 2002;109:143–145
  96. Berler DK, Alper MG. Scleral abscesses and ectasia caused by Pseudomonas aeruginosa. Ann Ophthalmol. 1982;14:665–667
  97. Farrell PL, Smith RE. Bacterial corneoscleritis complicating pterygium excision. Am J Ophthalmol. 1989;107:515–517
  98. Radford R, Brahma A, Armstrong M, et al. Severe sclerokeratitis due to Pseudomonas aeruginosa in noncontact-lens wearers. Eye. 2000;14(Pt l):3–7
  99. Reynolds MG, Alfonso E. Treatment of infectious scleritis and keratoscleritis. Am J Ophthalmol. 1991;112:543–547
  100. Casey R, Flowers CW, Jones DD, et al. Anterior nodular scleritis secondary to syphilis. Arch Ophthalmol. 1996;114:1015–1016
  101. Nanda M, Pflugfelder SC, Holland S. Mycobacterium tuberculosis scleritis. Am J Ophthalmol. 1989;108:736–737
  102. Bouza E, Merino P, Munoz P, et al. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore). 1997;76:53–61
  103. Benson WE. Posterior scleritis. Surv Ophthalmol. 1988;32:297–316
  104. Gupta V, Chawla R, Sen S. Aureobasidium pullulans scleritis following keratoplasty: a case report. Ophthalmic Surg Lasers. 2001;32:481–482
  105. Margo CE, Pavan PR. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol. 2000;118:1125–1128
  106. Dougherty PJ, Binder PS, Mondino BJ, et al. Acanthamoeba sclerokeratitis. Am J Ophthalmol. 1994;117:475–479
  107. Schuman JS, Weinberg RS, Ferry AP, et al. Toxoplasmic scleritis. Ophthalmology. 1988;95:1399–1403
  108. Hanssens M. A peculiar case of necrotizing sclerokeratitis with Pseudomonas infection. Bull Soc Beige Ophtalmol. 1995;259:45–52
  109. Cappin JM. Radiation scleral necrosis simulating early scleromalacia perforans. Br J Ophthalmol. 1973;57:425–428
  110. Scott JA, Clearkin LG. Surgically induced diffuse scleritis following cataract surgery. Eye. 1994;8(Pt 3):292–297
  111. Venkatesh P, Garg SP, Kumaran E, et al. Congenital porphyria with necrotizing scleritis in a 9-year-old child. Clin Experiment Ophthalmol. 2000;28:314–318
  112. Weston BC, White GL, Michalski JP. Scleritis associated with vitamin B12 deficiency. Can J Ophthalmol. 1998;33:283–284

PII: S1529-1839(04)70158-X

doi: 10.1016/S1529-1839(04)70158-X

Optometry - Journal of the American Optometric Association
Volume 75, Issue 7 , Pages 430-444 , July 2004

Article Tools